Articles by Jennifer Boggs

ABI In $4B Merger With APP To Create Abraxis BioScience

Nov. 29, 2005

American BioScience Inc. and its majority-owned subsidiary, American Pharmaceutical Partners Inc., are combining to create a new company, Abraxis BioScience. (BioWorld Today)

ABI In $4B Merger With APP To Create Abraxis BioScience

Nov. 29, 2005

By Jennifer Boggs

No Comments

American BioScience Inc. and its majority-owned subsidiary, American Pharmaceutical Partners Inc., are combining to create a new company, Abraxis BioScience. (BioWorld Today)

Required New Trial Of Vasovist Drops EPIX's Stock 14 Percent

Nov. 28, 2005

By Jennifer Boggs

No Comments

Required New Trial Of Vasovist Drops EPIX's Stock 14 Percent

Nov. 28, 2005

By Jennifer Boggs

No Comments

Nurel, Diamyd Combine GAD Technologies Through Merger

Nov. 23, 2005

By Jennifer Boggs

No Comments

Nurel, Diamyd Combine GAD Technologies Through Merger

Nov. 23, 2005

By Jennifer Boggs

No Comments

Solexa Raises $65M, Readies Sequencing System Launch

Nov. 22, 2005

By Jennifer Boggs

No Comments

Solexa Raises $65M, Readies Sequencing System Launch

Nov. 22, 2005

By Jennifer Boggs

No Comments

Gilead Reports Positive Truvada Data; FDA Probes Tamiflu Deaths

Nov. 21, 2005

By Jennifer Boggs

No Comments

Vernalis Buying Cita, Picking Up Third Parkinson's Product

Nov. 21, 2005

By Jennifer Boggs

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Articles by Jennifer Boggs

ABI In $4B Merger With APP To Create Abraxis BioScience

ABI In $4B Merger With APP To Create Abraxis BioScience

Required New Trial Of Vasovist Drops EPIX's Stock 14 Percent

Required New Trial Of Vasovist Drops EPIX's Stock 14 Percent

Nurel, Diamyd Combine GAD Technologies Through Merger

Nurel, Diamyd Combine GAD Technologies Through Merger

Solexa Raises $65M, Readies Sequencing System Launch

Solexa Raises $65M, Readies Sequencing System Launch

Gilead Reports Positive Truvada Data; FDA Probes Tamiflu Deaths

Vernalis Buying Cita, Picking Up Third Parkinson's Product

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal